While smoking remains the leading risk factor, other contributors include secondhand smoke, air pollution, radon exposure and ...

SAN ANTONIO, March 17, 2026--bioAffinity Technologies' new patient case study demonstrates the benefit of CyPath Lung in ...

The biopsy came back positive. It’s lung cancer.” Countless people in our community hear these words no one ever expects.

Diagnostic tunnel vision by 2 pulmonologists led to a $2 million malpractice settlement after the patient died of esophageal ...

L&T Technology Services has launched an AI-based lung digital twin platform designed for lung navigation, surgical planning, ...

With lung cancer the leading cause of cancer death both in the UK and globally, the UK's National Health Service (NHS) has launched a trial of AI lung scan analysis and robot-guided biopsies in an ...

An 18-year-old racing driver said he felt like he was living in "limbo" while waiting for test results following health ...

Three medical societies claim recent studies have overestimated the potential harms from lung cancer screening and may be deterring patients. Not everyone agrees.

The AI lung digital twin platform is built upon NVIDIA’s physical AI infrastructure.

The whole-body MRI machines whir, in conversation with the skeleton staring back at me on the computer screen. On a gray ...

LTTS has announced its next-generation, AI-powered digital twin platform for lung navigation, surgical planning and ...

Detailed price information for Bioaffinity Technologies Inc (BIAF-Q) from The Globe and Mail including charting and trades.